SKI Market

Indian Indices

Nifty

24,967.75 97.65
(0.39%)

Sensex

81,635.91 329.06
( 0.40%)

Bank Nifty

55,139.30 -10.10
( -0.02%)

Nifty IT

36,280.10 839.25
( 2.37%)

Global Indices

Nasdaq

45,305.71 -347.04
(-0.76%)

Dow Jones

6,460.93 -26.98
(-0.42%)

Hang Seng

42,789.96 156.67
(0.37%)

Nikkei 225

9,321.40 12.20
(0.13%)

Forex

USD-INR

87.17 0.12
(0.14%)

EUR-INR

101.39 0.01
(0.01%)

GBP-INR

117.16 -0.12
(-0.11%)

JPY-INR

0.59 0.00
(-0.18%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

506197

INE416D01022

100.3479373

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BLISSGVS

23.77

1677.41

EPS(TTM)

Face Value()

Div & Yield %

6.69

0.31

Back

BSL standalone net profit declines 79.65% in the June 2025 quarter

Aug 12,2025

Net profit of BSL declined 79.65% to Rs 0.47 crore in the quarter ended June 2025 as against Rs 2.31 crore during the previous quarter ended June 2024. Sales declined 3.49% to Rs 158.01 crore in the quarter ended June 2025 as against Rs 163.72 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	158.01	163.72	-3
OPM %	7.75	9.31	-
PBDT	4.84	7.62	-36
PBT	0.58	3.22	-82
NP	0.47	2.31	-80

24,967.75 97.65 (0.39%)

81,635.91 329.06 ( 0.40%)

55,139.30 -10.10 ( -0.02%)

36,280.10 839.25 ( 2.37%)

45,305.71 -347.04 (-0.76%)

6,460.93 -26.98 (-0.42%)

42,789.96 156.67 (0.37%)

9,321.40 12.20 (0.13%)

87.17 0.12 (0.14%)

101.39 0.01 (0.01%)

117.16 -0.12 (-0.11%)

0.59 0.00 (-0.18%)